Outcome of Board Meeting dated July 31, 2026

Outcome of Board Meeting dated July 31, 2026. Company, has acquired 100% of the equity share capital of Sulcus Private Limited (“Sulcus”) for a. consideration of ₹3.78 crore.

Reported results are the point at which prior management commitments become checkable against audited or reviewed numbers.

• Margin trend against the prior period
• Cash from operations against reported profit
• Whether prior guidance is reaffirmed
• The second year should be the breakeven year, which means that it will have to ramp up from now until then con (management committed by FY28)
• Oncology is yet to be fully launched, the radiation and LINAC, etcetera, should come in by end of the year. (management committed by Q4 FY27)